PepGen

PepGen Stock-Based Compensation

The Stock-Based Compensation (SBC) of PepGen (PEPG) as of Nov 19, 2026 is 10.61 M USD. In the previous year, Stock-Based Compensation (SBC) was 11.46 M USD — a change of -7.40% (lower).

Stock-Based Compensation

10.61 MUSD

YoY

-7.40%

Last updated:

Stock-Based Compensation (SBC) of PepGen is 2025 10.61 M USD. Stock-Based Compensation (SBC) of PepGen was 2024 11.46 M USD. It decreases by -7.40% lower compared to the previous year.

The PepGen Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2020
119,000.00 USD
Jan 1, 2021
1.53 M USD
Jan 1, 2022
4.76 M USD
Jan 1, 2023
7.05 M USD
Jan 1, 2024
11.46 M USD
Jan 1, 2025
10.61 M USD
The PepGen Stock-Based Compensation history
YEARStock-Based CompensationYoY
10.61 MUSD-7.40%
11.46 MUSD+62.56%
7.05 MUSD+47.97%
4.76 MUSD+210.50%
1.53 MUSD+1,189.08%
119,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PepGen Stock analysis

What does PepGen do? PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees. PepGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PepGen stock

Stock-Based Compensation (SBC) of PepGen is 10.61 M USD in 2025.

Stock-Based Compensation (SBC) of PepGen changed from 11.46 M USD to 10.61 M USD, representing a -7.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) PepGen since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s PepGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — PepGen

All Key Metrics — PepGen